Concepedia

Author

S. Hadziyannis

Hippocration General Hospital

Also Known As

S Hadziyannis, S J HADZIYANNIS, S. Hadziyannis, S. J. Hadziyannis, S.J. Hadziyannis, SJ Hadziyannis

37

Publications

1K

Citations

12

H-Index

26

Concepts

All Affiliations

Hippocration General HospitalNational and Kapodistrian University of AthensHenry Dunant HospitalWestern Attica General Hospital
SH

About

S. Hadziyannis is an author at Hippocration General Hospital specializing in medicine, hepatitis, and hepatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

267

2

Hepatology

3

3

134

3

Immunology

2

2

106

4

Pathology

2

2

106

5

Health Sciences

1

1

40

S. Hadziyannis

×

9

Publications

833

Citations

9

H-Index

YearCitations

Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B

Ferruccio Bonino, Patrick Marcellin, George Lau,

Gut

2006

262

Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy

Melanie Deutsch, Spyridon P. Dourakis, E.K. Manesis,

Hepatology

1997

183

Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose

S. Hadziyannis, Hugo Cheinquer, Timothy M. Morgan,

Journal of Hepatology

2002

133

Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays

Hannah Kuper, E. Kaklamani, S. Hadziyannis,

Cancer Causes & Control

2000

70

Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep).

Harry L.A. Janssen, J.T. Brouwer, F. Nevens,

BMJ

1993

66

Hepatic expression of the proliferative marker Ki‐67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma

John Koskinas, Kalliopi Petraki, Nikolaos Kavantzas,

Journal of Viral Hepatitis

2005

40

Recombinant interferon‐α therapy for acute hepatitis B: a randomized, double‐blind, placebo‐controlled trial

N.C. Tassopoulos, M. Koutelou, H. Polychronaki,

Journal of Viral Hepatitis

1997

31

Sustained viral load and ALT reduction following 48 weeks of entecavir treatment in subjects with chronic hepatitis B who have failed lamivudine.

Ting‐Tsung Chang, S. Hadziyannis, J Cianciara,

Hepatology

2002

28

Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations

I. Raptis, John Koskinas, T Emmanouil,

Journal of Viral Hepatitis

2003

20

Page 1